Transplantation Safety Trial Using Schwann Cells Completed Successfully


The Miami Project, at the University of Miami Miller School of Medicine, today announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord, in the February issue of the Journal of Neurotrauma.  Schwann cells are essential for the repair… Continue Reading »



Source link

Leave a Comment